Ligand Pharmaceuticals Incorporated (LGND) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Ligand Pharmaceuticals Incorporated (LGND) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $4.43B, listed on NASDAQ, employing roughly 68 people, carrying a beta of 1.07 to the broader market. Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Led by Todd C. Davis, public since 1992-11-18.
Snapshot as of May 15, 2026.
- Spot Price
- $215.00
- Total OI
- 1.5K